These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 16504600

  • 1. A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease.
    Packard C.
    Atheroscler Suppl; 2006 Apr; 7(1):21-9. PubMed ID: 16504600
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G, Maggioni AP.
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG.
    Am J Cardiol; 2008 Apr 01; 101(7):1009-15. PubMed ID: 18359323
    [Abstract] [Full Text] [Related]

  • 5. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.
    Rosenson RS.
    Am Heart J; 2006 Mar 01; 151(3):556-63. PubMed ID: 16504615
    [Abstract] [Full Text] [Related]

  • 6. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
    Ahmed MH.
    J Cardiovasc Med (Hagerstown); 2010 Nov 01; 11(11):858-60. PubMed ID: 20686417
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Statins and LDL-cholesterol lowering: an overview.
    Stroes E.
    Curr Med Res Opin; 2005 Nov 01; 21 Suppl 6():S9-16. PubMed ID: 16138936
    [Abstract] [Full Text] [Related]

  • 10. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.
    Indian Heart J; 2011 Nov 01; 63(3):211-27. PubMed ID: 22734339
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P.
    Am J Manag Care; 2009 Mar 01; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [Abstract] [Full Text] [Related]

  • 13. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov 01; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 14. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
    Clearfield MB.
    J Am Osteopath Assoc; 2010 Apr 01; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
    [Abstract] [Full Text] [Related]

  • 15. HDL-C: role as a risk modifier.
    Barter P.
    Atheroscler Suppl; 2011 Nov 01; 12(3):267-70. PubMed ID: 22152280
    [Abstract] [Full Text] [Related]

  • 16. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 01; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 17. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP, Mikhailidis DP, Moross T, Benson K, Gor M.
    Angiology; 2008 Apr 01; 59(1):36-46. PubMed ID: 18319220
    [Abstract] [Full Text] [Related]

  • 18. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA, Koro CE, Chan W, Bowlin SJ, Sprecher DL.
    Clin Ther; 2006 Feb 01; 28(2):243-50. PubMed ID: 16678645
    [Abstract] [Full Text] [Related]

  • 19. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I, Krone W.
    Dtsch Med Wochenschr; 2006 Dec 01; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [Abstract] [Full Text] [Related]

  • 20. Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid.
    Schima SM, Maciejewski SR, Hilleman DE, Williams MA, Mohiuddin SM.
    Expert Opin Pharmacother; 2010 Apr 01; 11(5):731-8. PubMed ID: 20210682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.